Tianeptine is a modified tricyclic compound (molecular formula C21H24ClN2NaO4S, CAS 66981-73-5) used exclusively in neuroscience research to study brain mechanisms related to stress, neuroplasticity, and opioid-monoamine pathway interactions. Unlike traditional tricyclic compounds, tianeptine demonstrates atypical mu-opioid receptor activity and modulates glutamate transmission in hippocampal and amygdala regions, making it valuable for investigating how opioid systems interface with mood regulation pathways in controlled laboratory settings.
Research applications include: neuroplasticity studies examining dendritic remodeling after chronic stress exposure, behavioral pharmacology protocols comparing novel mechanisms against standard compounds, molecular neuroscience investigations of receptor trafficking and signal transduction, and analytical chemistry method development for chromatographic separation techniques.
Key chemical properties: White crystalline powder, molecular weight 458.93 g/mol (sodium salt), highly water-soluble, melting point 180-182°C. Storage requires sealed containers at 2-8°C protected from light and moisture, with aqueous solutions prepared fresh due to limited stability.
CRITICAL RESEARCH LIMITATION: All information presented applies exclusively to controlled laboratory animal research under institutional review protocols. Published rodent studies employ doses ranging from 5-25 mg/kg (chronic) to 10-40 mg/kg (acute) via intraperitoneal or subcutaneous routes; these parameters provide no basis for extrapolation beyond academic understanding of research methodologies.
Chemical Structure and Classification
Tianeptine sodium (S 1574) belongs to the tricyclic antidepressant structural class, though its pharmacological profile differs substantially from traditional tricyclic compounds. The molecular formula C21H24ClN2NaO4S represents tianeptine sodium salt, while the free acid form carries the formula C21H25ClN2O4S.
The compound features a modified dibenzothiazepine nucleus with a heptanoic acid side chain attached to the nitrogen atom at position 11. This structural modification distinguishes tianeptine from conventional tricyclic compounds and contributes to its unique receptor binding profile.
Key chemical properties include:
-
Molecular weight: 458.93 g/mol (sodium salt)
-
Appearance: White to off-white crystalline powder
-
Solubility: Highly soluble in water and methanol
-
Melting point: Approximately 180-182°C
-
CAS Number: 66981-73-5 (sodium salt)
The compound exists primarily as the sodium salt form in research applications due to enhanced stability and solubility characteristics compared to the free acid.
Pharmacological Mechanisms in Research Models
Laboratory investigations have identified tianeptine's interaction with multiple neurochemical systems, making it a valuable tool for studying complex brain mechanisms.
Research has demonstrated tianeptine's activity at mu-opioid receptors in experimental models, with binding affinity studies showing interaction at these sites. This atypical property separates tianeptine from traditional antidepressant compounds and has prompted extensive investigation into opioid system involvement in mood regulation pathways.
Studies utilizing animal models have shown tianeptine modulates glutamate transmission in key brain regions including the hippocampus and amygdala. Research protocols examining synaptic plasticity have observed tianeptine's effects on AMPA receptor trafficking and dendritic spine morphology in cultured neurons.
Neurochemical analyses in rodent models have documented tianeptine's influence on serotonin reuptake, though through mechanisms distinct from selective serotonin reuptake inhibitors. Research suggests enhancement rather than inhibition of serotonin uptake in certain brain regions, representing an unusual pharmacological profile warranting continued investigation.
Research Applications and Laboratory Uses
Tianeptine serves multiple purposes in controlled research environments across neuroscience disciplines.
Neuroplasticity research utilizes tianeptine in protocols examining structural brain changes following chronic stress exposure in animal models. Studies have employed the compound to investigate dendritic remodeling in hippocampal neurons and stress-induced alterations in synaptic architecture.
Behavioral pharmacology laboratories incorporate tianeptine into experimental designs studying learning, memory consolidation, and behavioral responses to environmental stressors. Research protocols often compare tianeptine's effects against standard compounds to elucidate novel mechanisms.
Molecular neuroscience investigations use tianeptine as a research tool for exploring opioid receptor function, particularly regarding how opioid system activity interfaces with traditional monoamine pathways. Binding assays, receptor trafficking studies, and signal transduction research commonly employ tianeptine alongside selective opioid ligands.
Analytical chemistry laboratories utilize tianeptine as a reference standard in method development for chromatographic separation techniques, mass spectrometry protocols, and spectroscopic analysis procedures.
Experimental Dosing in Animal Models
Published research literature documents various dosing protocols employed in laboratory animal studies. These doses are provided strictly for research reference and academic understanding.
Common experimental doses in rodent models range from 5-25 mg/kg administered via intraperitoneal or subcutaneous routes. Chronic administration studies typically employ daily dosing over periods ranging from 7 to 21 days, depending on research objectives.
Acute administration studies often utilize single doses between 10-40 mg/kg to examine immediate pharmacological effects. Dose-response relationship investigations employ multiple groups receiving escalating doses to characterize concentration-dependent effects.
The route of administration significantly impacts pharmacokinetic parameters in research models. Oral gavage, intraperitoneal injection, and subcutaneous injection represent common administration methods in published protocols, each producing distinct absorption and distribution profiles.
Critical Research Note: These dosing parameters apply exclusively to controlled laboratory animal research under institutional review protocols. They provide no basis for extrapolation to other contexts and are presented solely for academic understanding of published research methodologies.
Stability and Storage Considerations for Research Applications
Proper handling and storage of tianeptine ensure compound integrity throughout research protocols.
Research-grade tianeptine sodium should be stored in tightly sealed containers protected from light exposure, moisture, and temperature fluctuations. Recommended storage temperatures range from 2-8°C for long-term stability, though room temperature storage remains acceptable for short periods when properly sealed.
Aqueous solutions of tianeptine sodium demonstrate limited stability and should be prepared fresh for experimental procedures. When solution preparation in advance becomes necessary, storage at 4°C in amber glass vials minimizes degradation. Most research protocols recommend using prepared solutions within 24-48 hours.
Desiccation represents a critical storage consideration as tianeptine sodium exhibits hygroscopic properties. Silica gel desiccant packages should accompany stored compounds to prevent moisture absorption that could compromise purity.
Analytical verification through high-performance liquid chromatography or mass spectrometry helps confirm compound identity and purity before use in critical research applications. Most suppliers provide certificates of analysis documenting purity levels typically exceeding 98%.
Analytical Characterization Methods
Research laboratories employ various analytical techniques to characterize tianeptine and verify compound identity.
High-performance liquid chromatography with UV detection at 230 nm represents a standard method for purity assessment and quantification in research samples. Reverse-phase columns with acetonitrile-phosphate buffer mobile phases achieve effective separation in published methods.
Mass spectrometry provides definitive structural confirmation through molecular ion detection and fragmentation pattern analysis. Electrospray ionization in positive mode typically yields [M+H]+ ions at m/z 437 for tianeptine free acid and [M+Na]+ ions at m/z 459 for the sodium salt.
Nuclear magnetic resonance spectroscopy enables complete structural elucidation with characteristic chemical shifts in both proton and carbon-13 spectra. Published NMR data provide reference spectra for compound verification.
Fourier-transform infrared spectroscopy identifies functional groups through characteristic absorption bands, including carbonyl stretches, aromatic C-H bends, and sulfur-containing heterocycle vibrations.
Comparative Analysis With Structurally Related Compounds
Understanding tianeptine's position within the broader landscape of tricyclic compounds provides research context.
Unlike traditional tricyclics such as imipramine or amitriptyline, tianeptine demonstrates minimal anticholinergic activity in receptor binding assays. This distinguishing characteristic makes it a valuable comparative tool when isolating specific pharmacological mechanisms in experimental designs.
The dibenzothiazepine nucleus shared with compounds like quetiapine provides structural similarities, though pharmacological profiles diverge substantially. Research comparing these structurally related molecules helps elucidate structure-activity relationships governing receptor selectivity.
Tianeptine's atypical opioid receptor activity contrasts sharply with traditional tricyclic compounds that lack significant opioid system engagement. This unique property has prompted research examining whether opioid mechanisms contribute to neuroplastic effects observed in preclinical models.
Research Safety Protocols and Laboratory Handling
Proper laboratory safety procedures protect researchers handling tianeptine in experimental settings.
Personal protective equipment, including nitrile gloves, laboratory coats, and safety glasses represents minimum requirements when handling tianeptine powder or solutions. Work should occur in adequately ventilated areas or under fume hood extraction when processing significant quantities.
Tianeptine demonstrates low acute toxicity in animal models, though standard chemical handling precautions apply. Avoid inhalation of powder, contact with skin or eyes, and accidental ingestion through proper hygiene practices, including thorough handwashing after handling.
Material safety data sheets provide comprehensive hazard information, first aid procedures, and disposal requirements specific to tianeptine sodium. Researchers should review these documents before initiating work with the compound.
Waste disposal must follow institutional chemical waste protocols and local regulations. Aqueous solutions can typically be collected in appropriate solvent waste containers, while solid waste should be packaged according to chemical disposal requirements.
Emerging Research Directions
Current scientific literature suggests several promising research directions involving tianeptine as an investigational tool.
Neuroinflammation research has begun exploring tianeptine's effects on microglial activation and cytokine expression in animal models of brain injury and neurodegenerative processes. Preliminary findings suggest modulation of inflammatory markers warranting further investigation.
Addiction neuroscience laboratories are investigating opioid receptor mechanisms using tianeptine to probe questions about reward circuitry, dependence liability in animal models, and receptor desensitization patterns. These studies aim to understand how combined opioid-monoamine activity influences behavioral outcomes.
Stress resilience research continues examining tianeptine's effects on hypothalamic-pituitary-adrenal axis function and glucocorticoid receptor expression in chronic stress paradigms. Understanding how the compound influences stress adaptation mechanisms remains an active research area.
Computational chemistry and molecular modeling studies are exploring tianeptine's binding conformations at various receptor sites to predict interaction dynamics and inform structure-activity relationship research for novel compound development.
Limitations and Research Considerations
Researchers should recognize certain limitations when incorporating tianeptine into experimental protocols.
Species differences in metabolism and receptor expression may limit translatability of findings between animal models. Rats and mice demonstrate distinct pharmacokinetic profiles that influence experimental design and interpretation.
The multi-target pharmacology creates challenges in attributing specific experimental outcomes to particular mechanisms. Research designs should incorporate selective antagonists or complementary approaches to isolate individual pathway contributions.
Limited availability of radiolabeled tianeptine compounds restricts certain experimental approaches, including autoradiography and detailed receptor binding kinetics. Researchers often must employ indirect methods to characterize receptor interactions.
Publication bias toward positive findings may overrepresent certain effects while underreporting null results. A comprehensive literature review should account for this potential bias when designing studies and interpreting outcomes.
Regulatory Status and Research Compliance
Tianeptine's regulatory classification varies internationally and affects research procurement and use.
In the United States, tianeptine is not FDA-approved for medical use but remains legal for research purposes in most jurisdictions, though several states have implemented scheduling restrictions. Researchers must verify current state and local regulations before procurement.
European countries maintain varied approaches, with some recognizing tianeptine as a prescription medication while others restrict its availability. Research institutions should consult local regulatory authorities regarding importation and use requirements.
Institutional review boards and animal care committees require protocol approval before tianeptine use in animal research. Applications should detail scientific rationale, dosing justification, and humane endpoints.
International shipping of tianeptine may require import permits, customs documentation, or controlled substance declarations, depending on the destination country's regulations. Researchers should work with institutional procurement offices to ensure compliance.
Conclusion
Tianeptine represents a valuable research tool for neuroscience laboratories investigating stress response mechanisms, neuroplasticity pathways, and opioid-monoamine system interactions. Its unique pharmacological profile, combining atypical mu-opioid receptor activity with glutamate modulation, distinguishes it from conventional tricyclic compounds and enables researchers to explore novel questions about brain function. When sourced from reputable suppliers like Nordic Chems, research-grade tianeptine maintains the purity and stability required for rigorous experimental protocols. Scientists must adhere to proper storage conditions, institutional safety protocols, and regulatory compliance requirements throughout their investigations. As research continues to uncover tianeptine's effects on neuroinflammation, stress resilience, and synaptic architecture, this compound will likely remain integral to advancing our understanding of brain chemistry and developing next-generation investigational approaches in controlled laboratory settings.
FINAL RESEARCH DISCLAIMER: This information is provided exclusively for educational and research purposes. Tianeptine is intended solely for qualified laboratory research and scientific investigation. It is NOT for human consumption, self-administration, or therapeutic use. Researchers must comply with all applicable institutional, local, state, and federal regulations governing research chemical use. Consult appropriate regulatory authorities and institutional review bodies before procuring or using tianeptine in research applications.
FAQs
What is tianeptine's molecular structure?
Tianeptine sodium (C21H24ClN2NaO4S) features a modified dibenzothiazepine nucleus with a heptanoic acid side chain. This tricyclic compound has a molecular weight of 458.93 g/mol and exists as a white crystalline powder highly soluble in water and methanol, with a melting point of 180-182°C.
How does tianeptine differ from traditional tricyclic compounds?
Unlike conventional tricyclics, tianeptine demonstrates atypical mu-opioid receptor activity and modulates glutamate transmission rather than primarily targeting monoamine reuptake. It shows minimal anticholinergic activity and enhances serotonin uptake in certain brain regions, an unusual mechanism distinguishing it from standard antidepressant research compounds.
What are proper storage conditions for research-grade tianeptine?
Store tianeptine sodium in tightly sealed containers at 2-8°C, protected from light and moisture. Use desiccant packages to prevent hygroscopic absorption. Prepare aqueous solutions fresh for experiments, or store at 4°C in amber vials for a maximum of 24-48 hours to minimize degradation.
What dosing ranges are used in animal research studies?
Published rodent studies employ chronic doses of 5-25 mg/kg daily (7-21 days) and acute doses of 10-40 mg/kg via intraperitoneal or subcutaneous routes. These parameters apply exclusively to controlled laboratory research under institutional protocols and provide no extrapolation beyond academic reference.
What analytical methods verify tianeptine purity?
High-performance liquid chromatography (UV detection at 230 nm), mass spectrometry (electrospray ionization showing m/z 437-459), nuclear magnetic resonance spectroscopy, and Fourier-transform infrared spectroscopy confirm tianeptine identity and purity, typically exceeding 98% in research-grade samples.
